Semaglutide linked to lower psychiatric hospitalization in bipolar disorder
A Swedish nationwide cohort linked semaglutide use to 21% lower psychiatric hospitalization risk in bipolar disorder, while other GLP-1 drugs did not.
Clinical evidence, research, and medical intelligence in Psychiatry.
Clinical evidence, research, and medical intelligence in Psychiatry.